Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/17401

TDMS Study 99035-01 Pathology Tables

NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04
Route: GAVAGE                                                                                                     Time: 12:51:24

                                                            FINAL #1




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  556-52-5

       Lock Date:  09/24/01

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          15           15           15           15           15                        
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 2            1            2            1            4                        
    Natural Death                                                                1                         2                        
  Survivors                                                                                                                         
    Terminal Sacrifice                                13           14           12           14            9                        
                                                                                                                                    
  Animals Examined Microscopically                    15           15           15           15           15                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Liver                                              (15)         (15)         (15)         (15)         (15)                      
      Angiectasis, Focal                                                                      1 (7%)       2 (13%)                  
      Eosinophilic Focus                                                                                   1 (7%)                   
      Hematopoietic Cell Proliferation                 2 (13%)      3 (20%)      1 (7%)       1 (7%)       2 (13%)                  
      Infiltration Cellular, Lymphoid                               3 (20%)      1 (7%)       1 (7%)       1 (7%)                   
      Inflammation                                                  1 (7%)                                                          
      Inflammation, Chronic                           11 (73%)     10 (67%)      8 (53%)      8 (53%)      7 (47%)                  
      Mixed Cell Focus                                                           1 (7%)       1 (7%)                                
      Necrosis, Focal                                                            5 (33%)      2 (13%)      2 (13%)                  
      Midzonal, Fatty Change                           1 (7%)                                                                       
   Stomach, Forestomach                               (15)         (15)         (15)         (15)         (15)                      
      Epithelium, Hyperplasia                                                                 1 (7%)       4 (27%)                  
   Stomach, Glandular                                 (15)         (15)         (15)         (15)         (15)                      
      Metaplasia, Squamous                                                       1 (7%)                                             
      Mineralization                                   4 (27%)                                             2 (13%)                  
      Epithelium, Ectasia                                                        1 (7%)                                             
      Muscularis, Mineralization                                                                           2 (13%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic                                                                                1 (7%)                   
      Myocardium, Mineralization                       1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (15)         (15)         (15)         (15)         (15)                      
      Hematopoietic Cell Proliferation                              1 (7%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Hyperplasia, Focal                                            2 (13%)                                1 (7%)                   
      Mineralization                                                                                       1 (7%)                   
      Vacuolization Cytoplasmic, Focal                 1 (7%)                                                                       
      Subcapsular, Hyperplasia                        15 (100%)    15 (100%)    10 (67%)     14 (93%)     15 (100%)                 
   Pituitary Gland                                    (15)         (15)         (15)         (15)         (15)                      
      Necrosis                                                                                             1 (7%)                   
      Pars Distalis, Hyperplasia, Focal                1 (7%)       1 (7%)       2 (13%)      1 (7%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                                                                         (1)                       
      Pigmentation, Melanin                                                                                1 (100%)                 
   Ovary                                              (15)         (15)         (15)         (15)         (15)                      
      Cyst                                             4 (27%)                                             2 (13%)                  
   Uterus                                             (15)         (15)         (15)         (15)         (15)                      
      Endometrium, Hyperplasia, Cystic                13 (87%)     14 (93%)     10 (67%)     14 (93%)      9 (60%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia                                                                                          1 (7%)                   
   Lymph Node                                         (13)         (15)         (15)         (13)         (14)                      
      Lumbar, Hyperplasia, Lymphoid                                 1 (7%)                                                          
      Mediastinal, Hyperplasia, Lymphoid               2 (15%)      1 (7%)                                                          
      Pancreatic, Hyperplasia, Lymphoid                                                                    1 (7%)                   
      Renal, Hyperplasia, Lymphoid                                                                         1 (7%)                   
   Lymph Node, Mandibular                             (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia, Lymphoid                            1 (7%)                                              1 (7%)                   
   Lymph Node, Mesenteric                             (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia, Lymphoid                                                                   1 (7%)                                
      Inflammation, Suppurative                        1 (7%)                                                                       
   Spleen                                             (15)         (15)         (15)         (15)         (15)                      
      Hematopoietic Cell Proliferation                 9 (60%)      5 (33%)     10 (67%)     10 (67%)     10 (67%)                  
   Thymus                                             (15)         (15)         (15)         (15)         (15)                      
      Atrophy                                                       2 (13%)                   1 (7%)       3 (20%)                  
      Hyperplasia, Lymphoid                                         1 (7%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia                                                                             1 (7%)                                
   Skin                                               (15)         (15)         (15)         (15)         (15)                      
      Subcutaneous Tissue, Edema                                                                           1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (15)         (15)         (15)         (15)         (15)                      
      Hyperostosis                                                                            1 (7%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (15)         (15)         (15)         (15)         (15)                      
      Cerebellum, Gliosis                                                                                  1 (7%)                   
      Cerebellum, Neuronopathy                                                                1 (7%)       3 (20%)                  
      Cerebrum, Cyst Epithelial Inclusion                                                                  1 (7%)                   
      Cerebrum, Hemorrhage                                                                    1 (7%)                                
      Medulla, Gliosis                                                                                     2 (13%)                  
      Medulla, Neuronopathy                                                                                3 (20%)                  
      Thalamus, Gliosis                                                                                    1 (7%)                   
      Thalamus, Neuronopathy                                                                               3 (20%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (15)         (15)         (15)         (15)         (15)                      
      Inflammation                                     8 (53%)      8 (53%)      7 (47%)      5 (33%)      3 (20%)                  
      Inflammation, Granulomatous                      1 (7%)                                                                       
      Alveolar Epithelium, Hyperplasia, Focal          1 (7%)       2 (13%)      1 (7%)                    1 (7%)                   
      Arteriole, Inflammation, Acute                   1 (7%)                                                                       
      Bronchus, Foreign Body                           1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (15)         (15)         (15)         (15)         (15)                      
      Infiltration Cellular, Lymphoid                               1 (7%)                                                          
      Metaplasia, Osseous                                                                                  1 (7%)                   
      Nephropathy                                     12 (80%)     12 (80%)     10 (67%)     14 (93%)      9 (60%)                  
      Renal Tubule, Accumulation, Hyaline Droplet                                2 (13%)      1 (7%)       3 (20%)                  
   Urinary Bladder                                    (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic                            1 (7%)                                                                       
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          15           15           15           15           15                        
  Early Deaths                                                                                                                      
    Natural Death                                      2            1            1            1            3                        
    Moribund Sacrifice                                                           1                         4                        
    Dosing Accident                                                                                        1                        
  Survivors                                                                                                                         
    Terminal Sacrifice                                13           14           13           14            7                        
                                                                                                                                    
  Animals Examined Microscopically                    15           15           15           15           15                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                                                    (1)                                                 
      Inflammation, Acute                                                        1 (100%)                                           
   Intestine Small, Jejunum                           (15)         (15)         (15)         (15)         (15)                      
      Peyer's Patch, Hyperplasia, Atypical                          1 (7%)                                                          
      Peyer's Patch, Hyperplasia, Lymphoid                          1 (7%)                                                          
   Liver                                              (15)         (15)         (15)         (15)         (15)                      
      Angiectasis, Focal                                                                                   1 (7%)                   
      Basophilic Focus                                              1 (7%)                                                          
      Degeneration, Cystic                             1 (7%)                                                                       
      Eosinophilic Focus                                                                                   1 (7%)                   
      Fatty Change, Focal                                                                     1 (7%)                                
      Hematopoietic Cell Proliferation                              1 (7%)                    2 (13%)      1 (7%)                   
      Hemorrhage                                                                 1 (7%)                                             
      Infiltration Cellular, Lymphoid                  1 (7%)       2 (13%)                   2 (13%)      1 (7%)                   
      Inflammation, Chronic                            6 (40%)      9 (60%)      8 (53%)      9 (60%)      2 (13%)                  
      Mixed Cell Focus                                                                        1 (7%)                                
      Necrosis, Focal                                  1 (7%)       2 (13%)      2 (13%)                   5 (33%)                  
   Mesentery                                                       (1)                                                              
      Fat, Necrosis                                                 1 (100%)                                                        
   Stomach, Forestomach                               (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic                                                                                1 (7%)                   
      Ulcer                                                         1 (7%)                                 3 (20%)                  
      Epithelium, Hyperplasia                                       1 (7%)       1 (7%)                    6 (40%)                  
   Stomach, Glandular                                 (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic                                                      1 (7%)                                             
      Mineralization                                  10 (67%)                                5 (33%)      1 (7%)                   
      Ulcer                                                                                                1 (7%)                   
      Epithelium, Hyperplasia                                       1 (7%)                                                          
      Glands, Ectasia                                                            1 (7%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Muscularis, Mineralization                                                              1 (7%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (15)         (15)         (15)         (15)         (15)                      
      Infiltration Cellular, Mast Cell                                                                     1 (7%)                   
      Epicardium, Inflammation, Chronic                1 (7%)                                                                       
      Myocardium, Degeneration                         2 (13%)                                2 (13%)                               
      Myocardium, Mineralization                                                 2 (13%)      1 (7%)       5 (33%)                  
      Myocardium, Necrosis                                                                                 2 (13%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (15)         (15)         (15)         (14)         (15)                      
      Hyperplasia, Focal                               1 (7%)                                 1 (7%)                                
      Subcapsular, Hyperplasia                         1 (7%)       2 (13%)      2 (13%)      3 (21%)      1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (15)         (15)         (15)         (15)         (15)                      
      Fibrosis                                                      1 (7%)                                                          
   Preputial Gland                                                              (1)                                                 
      Inflammation, Suppurative                                                  1 (100%)                                           
   Testes                                             (15)         (15)         (15)         (15)         (15)                      
      Germinal Epithelium, Degeneration                             1 (7%)                                 1 (7%)                   
      Germinal Epithelium, Mineralization                           1 (7%)                                                          
      Germinal Epithelium, Necrosis                    1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                         (14)         (14)         (15)         (13)         (13)                      
      Mediastinal, Hyperplasia, Lymphoid                            1 (7%)                                                          
   Lymph Node, Mandibular                             (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia, Lymphoid                                         2 (13%)                   1 (7%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Inflammation, Suppurative                                                  1 (7%)                                             
      Necrosis                                                                                             1 (7%)                   
   Lymph Node, Mesenteric                             (15)         (15)         (15)         (14)         (15)                      
      Hematopoietic Cell Proliferation                              1 (7%)                                                          
      Hyperplasia, Lymphoid                                         2 (13%)                   1 (7%)       1 (7%)                   
      Inflammation, Suppurative                                     1 (7%)                                 1 (7%)                   
      Necrosis                                                                                             1 (7%)                   
   Spleen                                             (15)         (15)         (15)         (15)         (15)                      
      Angiectasis                                                                                          1 (7%)                   
      Atrophy                                                                                 1 (7%)       2 (13%)                  
      Hematopoietic Cell Proliferation                 4 (27%)      7 (47%)      7 (47%)      5 (33%)      5 (33%)                  
   Thymus                                             (15)         (15)         (15)         (15)         (15)                      
      Atrophy                                          2 (13%)                   1 (7%)                    4 (27%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (15)         (15)         (15)         (15)         (15)                      
      Ulcer                                                                                                1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (15)         (15)         (15)         (15)         (15)                      
      Hyperostosis                                     1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (15)         (15)         (15)         (15)         (15)                      
      Mineralization                                   1 (7%)                                                                       
      Cerebellum, Gliosis                                                                                  2 (13%)                  
      Cerebellum, Hemorrhage, Focal                                                                        1 (7%)                   
      Cerebellum, Neuronopathy                                                                             3 (20%)                  
      Cerebrum, Hemorrhage                                                                                 1 (7%)                   
      Cerebrum, Necrosis, Focal                                                                            2 (13%)                  
      Hippocampus, Hemorrhage                                                                              1 (7%)                   
      Hippocampus, Necrosis                                                      1 (7%)                    1 (7%)                   
      Medulla, Gliosis                                                                                     2 (13%)                  
      Medulla, Neuronopathy                                                                                3 (20%)                  
      Thalamus, Gliosis                                                                                    2 (13%)                  
      Thalamus, Neuronopathy                                                                               5 (33%)                  
   Spinal Cord                                                                               (1)                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
NERVOUS SYSTEM - CONT                                                                                                               
      Axon, Degeneration                                                                      1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (15)         (15)         (15)         (15)         (15)                      
      Hemorrhage                                                                                           1 (7%)                   
      Inflammation                                     3 (20%)      7 (47%)      5 (33%)      4 (27%)      2 (13%)                  
      Inflammation, Granulomatous                                                1 (7%)                                             
      Alveolar Epithelium, Hyperplasia, Focal                       2 (13%)                   2 (13%)      2 (13%)                  
      Bronchiole, Hyperplasia                                                    1 (7%)                                             
      Vein, Thrombosis                                                           1 (7%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (15)         (15)         (15)         (15)         (15)                      
      Hydronephrosis                                                                                       1 (7%)                   
      Infarct                                                                                              1 (7%)                   
      Nephropathy                                      4 (27%)      5 (33%)      5 (33%)      4 (27%)      4 (27%)                  
      Renal Tubule, Accumulation, Hyaline Droplet                                1 (7%)                    1 (7%)                   
   Urinary Bladder                                    (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic                                                                                1 (7%)                   
      Transitional Epithelium, Hyperplasia             1 (7%)                                                                       
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------